$94.71
2.73%
NYSE, Oct 10, 10:00 pm CET
ISIN
US98956P1021
Symbol
ZBH

Zimmer Biomet Holdings, Inc. Stock price

$94.71
-7.59 7.42% 1M
-7.55 7.38% 6M
-10.92 10.34% YTD
-8.11 7.89% 1Y
-12.23 11.44% 3Y
-49.98 34.54% 5Y
+1.08 1.16% 10Y
+31.14 48.98% 20Y
NYSE, Closing price Fri, Oct 10 2025
-2.66 2.73%

Key metrics

Basic
Market capitalization
$19.6b
Enterprise Value
$26.6b
Net debt
$7.0b
Cash
$556.9m
Shares outstanding
197.9m
Valuation (TTM | estimate)
P/E
22.8 | 11.5
P/S
2.5 | 2.4
EV/Sales
3.4 | 3.2
EV/FCF
22.3
P/B
1.6
Dividends
DPS
$0.96
Yield 1Y | 5Y
1.0% | 0.8%
Growth 1Y | 5Y
0.0% | 0.6%
Payout 1Y | 3Y
21.7% | 27.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$7.8b | $8.3b
EBITDA
$2.1b | $2.9b
EBIT
$1.5b | $2.3b
Net Income
$823.4m | $1.6b
Free Cash Flow
$1.2b
Growth (TTM | estimate)
Revenue
4.1% | 8.2%
EBITDA
0.8% | 33.3%
EBIT
-1.6% | 45.4%
Net Income
-17.4% | 80.4%
Free Cash Flow
43.8%
Margin (TTM | estimate)
Gross
71.1%
EBITDA
27.1% | 34.5%
EBIT
19.3%
Net
10.5% | 19.6%
Free Cash Flow
15.2%
Financial Health
Equity Ratio
58.4%
Return on Equity
7.3%
ROCE
7.5%
ROIC
6.3%
Debt/Equity
0.6
More
EPS
$4.2
FCF per Share
$6.0
Short interest
3.9%
Employees
17k
Rev per Employee
$450.0k
Show more

Is Zimmer Biomet Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,999 stocks worldwide.

Zimmer Biomet Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

35 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

15x Buy
43%
18x Hold
51%
2x Sell
6%

Analyst Opinions

35 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

Buy
43%
Hold
51%
Sell
6%

Financial data from Zimmer Biomet Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
7,834 7,834
4% 4%
100%
- Direct Costs 2,267 2,267
7% 7%
29%
5,567 5,567
3% 3%
71%
- Selling and Administrative Expenses 2,997 2,997
5% 5%
38%
- Research and Development Expense 444 444
1% 1%
6%
2,126 2,126
1% 1%
27%
- Depreciation and Amortization 617 617
7% 7%
8%
EBIT (Operating Income) EBIT 1,508 1,508
2% 2%
19%
Net Profit 823 823
17% 17%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Zimmer Biomet Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zimmer Biomet Holdings, Inc. Stock News

Positive
Seeking Alpha
about 20 hours ago
Zimmer Biomet Holdings is rated a BUY, driven by innovation momentum and undervalued valuation despite recent stock underperformance. ZBH's 'Magnificent 7' products, strategic acquisitions like Monogram Technologies, and strong cash flow underpin a compelling medium- to long-term investment thesis. Key risks include acquisition integration, margin pressure, regulatory challenges, and operationa...
Neutral
PRNewsWire
5 days ago
Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries WARSAW, Ind., Oct. 8, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, a wholly owned subsidiary, today announced the full commercial launch of two innovative solution...
Neutral
PRNewsWire
6 days ago
Transaction creates the  broadest, most flexible portfolio of orthopedic robotics and navigation technologies, including pathway towards the first fully autonomous robotic technology for orthopedic procedures  WARSAW, Ind., Oct. 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ("Zimmer Biomet"), a global medical technology leader, today announced it has completed the acq...
More Zimmer Biomet Holdings, Inc. News

Company Profile

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Head office United States
CEO Ivan Tornos
Employees 17,000
Founded 1927
Website www.zimmerbiomet.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today